Aardvark Therapeutics Common Stock Statistics Share Statistics Aardvark Therapeutics Common Stock has 21.7M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 21.7M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) 65.83% Shares Floating n/a Failed to Deliver (FTD) Shares 1,867 FTD / Avg. Volume 3.67%
Short Selling Information The latest short interest is 663.81K, so 3.06% of the outstanding
shares have been sold short.
Short Interest 663.81K Short % of Shares Out 3.06% Short % of Float 4.7% Short Ratio (days to cover) 16.66
Valuation Ratios The PE ratio is -8.97 and the forward
PE ratio is -4.57.
Aardvark Therapeutics Common Stock's PEG ratio is
-0.05.
PE Ratio -8.97 Forward PE -4.57 PS Ratio 0 Forward PS 401 PB Ratio -3.38 P/FCF Ratio -10.15 PEG Ratio -0.05
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Aardvark Therapeutics Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 15.05,
with a Debt / Equity ratio of -0.01.
Current Ratio 15.05 Quick Ratio 15.05 Debt / Equity -0.01 Debt / EBITDA -0.03 Debt / FCF -0.04 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-935.82K Employee Count 22 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is 2.82, so Aardvark Therapeutics Common Stock's
price volatility has been higher than the market average.
Beta 2.82 52-Week Price Change n/a 50-Day Moving Average 12.47 200-Day Moving Average n/a Relative Strength Index (RSI) 45.12 Average Volume (20 Days) 50,893
Income Statement
Revenue n/a Gross Profit n/a Operating Income -22.79M Net Income -20.59M EBITDA -22.79M EBIT -22.67M Earnings Per Share (EPS) -1.59
Full Income Statement Balance Sheet The company has 61.64M in cash and 779K in
debt, giving a net cash position of 60.86M.
Cash & Cash Equivalents 61.64M Total Debt 779K Net Cash 60.86M Retained Earnings -58.33M Total Assets 157.03M Working Capital 148.58M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -18.09M
and capital expenditures -109K, giving a free cash flow of -18.2M.
Operating Cash Flow -18.09M Capital Expenditures -109K Free Cash Flow -18.2M FCF Per Share -1.41
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
